Introduction
Pityriasis rubra pilaris (PRP) is a chronic disorder of keratinization of unclear pathogenesis [1] . It typically manifests as erythematous and scaly cutaneous plaques with islands of spared skin associated with follicular scaly papules and orange palmar and plantar keratoderma.
Although PRP is usually idiopathic, certain trigger events have occasionally been reported, mainly traumatic, infectious (infections of streptococcus, cytomegalovirus and rubella) or after vaccination [2] . However, PRP-like eruptions induced by drugs have been described, albeit rarely [3] [4] [5] .
We report a case of PRP-like eruption that occurred during the initiation of insulin therapy. To our knowledge, no previous similar cases have been reported.
Case report
A 29-year-old man was referred to our department because of a generalized erythematosquamous and non-pruritic derPityriasis rubra pilaris-like eruption following insulin therapy initiation Pityriasis rubra pilaris (PRP) is a chronic disorder of keratinization of unclear pathogenesis. PRP-like eruptions induced by drugs have rarely been described. A previously healthy 29-year-old man presented with a generalized, rapidly spreading, erythematosquamous dermatosis, that started three days after initiation of subcutaneous insulin therapy for diabetes mellitus type 1. Clinical and histopathological features were consistent with a PRP-like eruption, possibly due to insulin therapy. The patient was switched to insulin analogue therapy and a complete healing of all lesions was achieved after two months. No recurrence was seen after one year of follow-up.
Other possible etiologies of PRP were excluded. The mechanism leading to the occurrence of drug-induced PRP-like eruptions are not clear. Since PRP may occur in the context of immunological anomalies, it is possible that diabetes mellitus type 1 may have been a predisposing condition for the development of PRP in this case.
ABSTRACT Histopathology
A skin biopsy was performed, and histopathological examination revealed irregular hyperkeratosis with orthokeratosis and parakeratosis in addition to dilated hair follicles and keratinous plugs (Figure 3 ).
Diagnosis and outcome
A diagnosis of a PRP-like eruption, possibly induced by insulin therapy, was suspected. Insulatard ® and Actrapid 
Discussion
The acute onset of the dermatosis after insulin therapy initiation, the rapid favorable outcome after human insulin cidated [2] [3] [4] [5] . The pathogenesis in our patient is also unclear.
Although insulin therapy is largely used worldwide, its association with PRP-like eruptions has never been reported.
However, since PRP may occur in certain cases with underlying immunological anomalies [2] , it is possible that diabetes mellitus type 1 might have contributed to the development of the dermatosis in our patient, after insulin therapy initiation.
Insulin preparations containing zinc or protamine (such as Insulatard ® ) may also cause a delayed-type hypersensitivity [6, 7] . However, in the absence of skin tests, the role of such additives in the genesis of the dermatosis in our patient could not be determined.
Conclusion
Although a fortuitous association could not totally be ruled out, a cutaneous reaction induced by insulin therapy in a context of underlying immunological anomalies might be the cause of the dermatosis in our patient.
